Buscar

Today, Renown Health announced the appointment of William “Bill” Plauth, MD, MMM, CPE as Chief Medical Officer for Renown Health, effective 3 de abril de 2023. “I am excited to have Dr. Plauth join our team," said Brian Erling, MD, MBA, President & CEO of Renown Health. “Dr. Plauth is a distinguished physician with over 30 years of experience. Dr. Plauth’s extensive commitment to service is in alignment with our mission, vision, and values. He is a goal-oriented, collaborative executive who brings a depth of experience to Renown Health and to our community. He inspires others with his intelligence and proven abilities to engage others in advancing clinical quality and performance. I look forward to the strides our health system will make in helping people live better and healthier lives under his leadership.” In his role as Chief Medical Officer (CMO), Dr. Plauth will be responsible for continuous quality improvement, effective clinical resource management and serve as a liaison for organized medical staff activities. He will partner with nursing leadership to actively support performance improvement, risk management, and efficient resource utilization linked to evidence-based medicine. He will listen and foster a close relationship between and among physicians, management, and clinical staff. As CMO, Dr. Plauth will provide expertise, coordination, and leadership in support of elected medical staff leaders and partner with UNR Med leadership to ensure a positive training environment across Renown Health. “As a physician, I have always been humbled by the trust our patients and their families invest in all of us as a healthcare team,” says Bill Plauth, MD. “Over the years, to fulfill that trust, I have enjoyed engaging with my colleagues across clinical teams to adopt innovative approaches that respect those who do the work and to promote ease of practice. Such collaboration makes it possible for us to provide top-notch, compassionate care that addresses our patients' unique challenges and to improve their health and quality of life. At the end of the day, it is the people that make the difference.” Dr. Plauth adds, “I am delighted to join Renown Health, which as a not-for-profit, charitable health care organization has a long history of compassionate service. I look forward to working with my new medical, nursing, and administrative colleagues as we fulfill our mission of making a genuine difference in the health and wellbeing of the people and communities we serve.” Renown Health has more than 7,200 employees and serves Northern Nevada, Lake Tahoe, and Northeast California. The system includes Renown Regional Medical Center, Renown South Meadows Medical Center, Renown Rehabilitation Hospital and Renown Children’s Hospital. Renown also has over 50 medical group, urgent care, and outpatient imaging practices. Hometown Health is the insurance division of Renown Health and is northern Nevada’s largest local, not-for- profit health insurance company that provides wide-ranging medical coverage. Since 2014, Dr. Plauth has provided clinical leadership at Centura Health (CO), first serving as Chief Medical Officer at Mercy Regional Medical Center in Durango, CO, and then for the last four years as Chief Medical Officer for Centura Penrose & St. Francis Hospitals in Colorado Springs. He was responsible for clinical quality, high reliability patient safety initiatives, process improvement, pharmacy, care management, infection control and medical staff services. Formerly, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then with concurrent roles that included Chief of Staff; Medical Director, Clinical Informatics; Medical Director, Palliative Care and Acting Chief Medical Officer for Quality and Medical Staff Affairs. Board certified in both Internal Medicine and Hospice & Palliative Care, Dr. Plauth is a leader in quality improvement, patient safety and clinical informatics. He has also served as a medical director of a Long-Term Care and Skilled Nursing Center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his Medical Doctorate from Emory University in Atlanta with a sub-internship at Brigham and Women’s Hospital in Boston. He completed his internship and residency at University of California San Francisco, where he also served as Chief Resident. In the most recent U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada. Ningún otro hospital en Nevada obtuvo el reconocimiento de U.S. News. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit www.renown.org/careers.

Leer más About William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health

Renown Health se complace en anunciar que Susan Lee, DO, MBA, se desempeñará como directora de operaciones del Renown South Meadows Medical Center. La Dra. Lee asume su nueva función el 7 de marzo y sucede a Chris Nicholas, quien renunció el mes pasado para tomar un puesto en un sistema de salud de Florida. Tony Slonim, MD, DrPH, presidente y director ejecutivo de Renown Health, anunció hoy el ascenso interno de la Dra. Lee con las siguientes palabras: “En consonancia con nuestra visión de mejorar la salud de la comunidad, empoderamos a los líderes para que desempeñen un papel más importante en la mejora de las experiencias de los médicos, los empleados y los pacientes; en la ampliación de servicios para nuestra comunidad; en la prestación de atención exacta y confiable, y en el cumplimiento de estándares rigurosos de excelencia y eficacia operativa”. El Dr. Slonim comentó que estaba entusiasmado ya que “La Dra. Lee amplía su función, promueve un espíritu de unidad en toda la empresa y continúa progresando para lograr metas fundamentales para el éxito de Renown”. En su nueva función como directora de operaciones del Renown South Meadows Medical Center, la Dra. Lee trabajará con Jennifer Allen, máster en enfermería, directora de enfermería, y el equipo y el personal médico de liderazgo del South Meadows para conducir al South Meadows hacia el logro de sus objetivos estratégicos y operativos. La Dra. Lee es una médica ejecutiva experimentada y dinámica y una líder operativa con trayectoria en crecimiento de servicios, calidad clínica, comunicación con los pacientes y ejecución. Tiene experiencia en colaboración interfuncional y es reconocida a nivel nacional por la administración de cambios organizacionales. La Dra. Lee, certificada por el consejo en medicina interna y psiquiatría, ha basado su práctica clínica como médica hospitalaria en la conexión entre la mente y el cuerpo y en un modelo de colaboración con pacientes y familias. La Dra. Lee se unió a Renown Health como presidenta de Especialidades Médicas en el verano de 2020 para administrar las prácticas médicas hospitalarias. Fue ascendida a directora médica del Renown Regional Medical Center en febrero de 2021 para supervisar las operaciones clínicas de pacientes hospitalizados, incluyendo duración de la hospitalización, capacidad hospitalaria, funcionalidad de administración de la atención, rondas interdisciplinarias y servicios para el personal médico. Desde septiembre de 2021, como directora médica de Cuidados Intensivos de Renown, ha sido responsable de las operaciones clínicas, de la dirección estratégica, de la gestión de médicos por hospital, de la Oficina del Personal Médico, de los estándares regulatorios y de los resultados financieros y de calidad para el Renown Regional Medical Center, el Renown South Meadows Medical Center y el Renown Rehabilitation Hospital. Antes de trabajar en Renown, la Dra. Lee se desempeñó como jefa de Medicina Hospitalaria en Carilion Clinic, un sistema de salud integrado sin fines de lucro con siete centros y sede central en Roanoke, Virginia. La Dra. Lee es egresada de la University of Massachusetts Amherst (MBA), la Facultad de Medicina Osteopática (DO) de la Nova Southeastern University y de la Duke University (BA). Es miembro activo del American College of Healthcare Executives y de la American Association for Physician Leadership. El Renown South Meadows Medical Center, ubicado en el sur de Reno, es un hospital comunitario de cuidados intensivos con 76 camas que ofrece servicios médicos y quirúrgicos excepcionales en un ambiente propicio. El Renown South Meadows Medical Center alberga al único Departamento de Emergencias 24/7 del sur de Reno y cuenta con médicos de emergencia certificados por el consejo. El Renown South Meadows Medical Center ofrece atención avanzada a los pacientes, lo cual incluye atención primaria integral; servicios de radiografías e imágenes; servicios de laboratorio; atención cardíaca; obstetricia/ginecología; servicios de rehabilitación física y de rehabilitación pulmonar; medicina nuclear y servicios quirúrgicos, que incluyen ortopedia. Como organización sin fines de lucro, el equipo del Renown South Meadows Medical Center acepta su papel en mejorar la salud y el bienestar de las personas y las comunidades a las que sirven y presta los servicios de atención médica necesarios, independientemente de la raza, el credo, el sexo, la nacionalidad, la discapacidad, la edad o la capacidad de pago. Además, el Renown South Meadows Medical Center ha sido reconocido a nivel nacional por brindar atención y servicios de la más alta calidad. Entre las menciones se incluyen: En los rankings de mejores hospitales de U.S. News and World Report, el Renown South Meadows ocupa el primer puesto en el estado de Nevada (junto con el Carson Tahoe Medical Center) para 2020. El Renown South Meadows obtuvo la calificación de sobresaliente para reemplazo de cadera, reemplazo de rodilla y enfermedad pulmonar obstructiva crónica (EPOC). La calificación de un hospital se basa en múltiples categorías de datos, que incluyen resultados de los pacientes, seguridad y volúmenes. Los hospitales calificados como sobresalientes eran significativamente mejores que el promedio nacional. El Renown South Meadows Medical Center recibió la acreditación The Joint Commission’s Gold Seal of Approval® para reemplazo total de rodilla, reemplazo total de cadera y reemplazo total de hombro y fue reconocido en el programa Top Performer on Key Quality Measures®. La Dra. Lee dice que “entiende que la atención médica actual se trata tanto de las habilidades sociales y de navegar diferentes relaciones como del conocimiento clínico”. A lo largo de su carrera profesional, la Dra. Lee ha hecho mucho para contribuir a una cultura de innovación y transformación. La Dra. Lee cree que “los proveedores necesitan médicos, enfermeros y equipos de atención que tengan una alta adaptabilidad, flexibilidad y, sobre todo, la capacidad de cuidar de otros y ser amables”. La Dra. Lee brinda asesoramiento a los equipos para que sean receptivos, empáticos, conscientes de la situación y empleen sus habilidades clínicas en el nivel más alto. A menudo formulará preguntas a su equipo para comprender cómo están “programados”, a fin de impulsar la innovación y la transformación, y fomentar la cultura y el trabajo en equipo. Ha contratado y capacitado a más de 100 médicos hospitalarios, muchas de ellas mujeres, y ha ascendido y servido como referencia para cientos de enfermeros, líderes de personal y proveedores de atención avanzada. La Dra. Lee se desempeña como mentora para otras mujeres y hombres que aspiran al liderazgo médico y de la atención médica. El equipo del Renown South Meadows Medical Center está en la búsqueda de excelentes empleados para ocupar puestos de servicio; postule en línea en https://careers.renown.org/.

Leer más About La Dra. Susan Lee dirigirá el Renown South Meadows Medical Center

Dr. Max J. Coppes announced as Cancer Center Directory, Larry Duncan as Cancer Center Administrator for Renown's Institute for Cancer, with goal to improve the health and well-being of Nevadans. Renown Health is excited to announce that effective today, Max J. Coppes, MD, PhD, MBA has been appointed to a new leadership role as the Cancer Center Director for Renown’s Institute for Cancer. Dr. Coppes, a pediatric oncologist by training, has experience in leading large-scale, nationally-recognized academic adult and pediatric cancer center teams in both the U.S. and Canada. “If you know Dr. Coppes, you know he has the passion, dedication and commitment to build and foster the partnerships needed to create a leading comprehensive cancer center and program that spans the spectrum for patients and their families; from prevention to treatment to survivorship to palliative care,” said Tony Slonim, MD, DrPH, President and CEO, Renown Health. Also effective today, Larry Duncan, MS, has been appointed as Cancer Center Administrator for Renown Health, working in dyad partnership with Dr. Coppes to support the development of this important service line. Larry will also continue his service as Vice President of Pediatrics and Surgery & Administrator of Renown Children's & Women’s Services “Together, as they have done so successfully for Renown Children’s Hospital, Dr. Coppes and Larry Duncan will be responsible for the strategic direction, operations, fiscal management and recruitment of professionals to the Renown Institute for Cancer,” said Sy Johnson, MBA, chief of staff for Renown Health. “As one of Renown’s ‘Destination Health’ service lines, Dr. Coppes and Larry will continue to support an integrated leadership model that puts the patient at the center of all that we do.” El Dr. Coppes llegó a Reno en 2014 procedente de la British Columbia Cancer Agency de Vancouver, donde ocupó el cargo de presidente responsable de seis centros oncológicos regionales y dos centros de investigación del cáncer. He was an attending physician at BC Children's Hospital, an adjunct professor of Health Sciences at Simon Fraser University, and a professor of Medicine and Pediatrics at the University of British Columbia. During his career, Coppes served as senior vice president at Children's National Medical Center in Washington, D.C. and held positions at several prestigious facilities in the U.S. and Canada including The Hospital for Sick Children (SickKids) in Toronto, Georgetown University, The National Cancer Institute, and the Cleveland Clinic. Desde 2016, el Dr. Coppes se ha desempeñado en el rol de liderazgo conjunto como presidente de Pediatría del centro Nell J. Redfield de la Facultad de Medicina de la University of Nevada y pediatra en jefe del Renown Children’s Hospital, un puesto que ha sido posible gracias al generoso apoyo filantrópico de la Nell J. Redfield Foundation junto con las inversiones de Renown Health y la Facultad de Medicina de la UNR. Over the last five years, Duncan has served as Vice President of Pediatrics and Surgery & Administrator of Renown Children's and Women's Hospital, with oversight for Renown’s Pediatric Emergency Room and general and specialty pediatric physician practices. He has also served as Chief Operating Officer for Renown Regional Medical Center with oversight of pharmacy, imaging, nutrition, laboratory services and operating rooms. Antes de llegar a Renown, Duncan fue director general de El Paso Children’s Hospital y ocupó cargos ejecutivos en el Children’s Hospital of Wisconsin, el Children’s Hospital of Philadelphia y el Rush University Medical Center. “El Renown Institute for Cancer cuenta con la acreditación completa y distinción de la Comisión sobre el Cáncer del American College of Surgeons en todas las 7 áreas. Solo el 25 % de los programas oncológicos alcanzan esta distinción, que reconoce la calidad de la atención integral y multidisciplinar al paciente. Renown is the only accredited Community Hospital Comprehensive Cancer program in northern Nevada to be selected, and one of only three programs statewide,” says Max J. Coppes, MD, PhD, MBA. “That is certainly an excellent foundation on which to build on, and such a gift for our community.”  “Renown’s cancer nurses, patient navigators, social workers, palliative care specialists, geneticists, nutritionists, clinical trial researchers, physical rehab specialists and the entire team provides prevention and screening to help reduce the incidence of cancer and reduce the late stage presentation of cancers,” says Larry Duncan, MS. “Helping patients and families navigate their journey begins at the time of diagnosis, with the help of our nurse navigators, and extends throughout the patient’s treatment. Estamos avanzando en la supervivencia a largo plazo y nos complace ser reconocidos por la naturaleza integral de nuestros programas de investigación, atención, educación y divulgación comunitaria”. De acuerdo con el Instituto Nacional del Cáncer, la tasa de mortalidad ajustada por edad de 153.5 en 100,000 habitantes debido al cáncer en el condado de Washoe ha experimentado una mejora significativa en los últimos años, y ahora cumple el objetivo nacional de salud de Healthy People para 2020, que consiste en reducir la tasa global de mortalidad por cáncer por debajo de 161.4 en 100,000 habitantes. El objetivo nacional de salud de Healthy People 2030 es reducir la tasa global de mortalidad por cáncer a 122.7 muertes en 100,000 habitantes. El Instituto Nacional del Cáncer (National Cancer Institute, NCI) define el cáncer como un término utilizado para describir enfermedades en las que células anormales se dividen sin control y son capaces de invadir otros tejidos. Según el NCI, existen más de 100 tipos diferentes de cáncer, pero el cáncer de mama, colon, pulmón, páncreas, próstata y recto produce la mayor cantidad de muertes anuales. Risk factors of cancer include but are not limited to; age, alcohol use, tobacco use, a poor diet, certain hormones, and sun exposure. Although some of these risk factors cannot be avoided -- such as age -- limiting exposure to avoidable risk factors may lower risk of developing certain cancers. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . Para obtener más información, visite www.renown.

Leer más About Renown Health anuncia el equipo de liderazgo del programa contra el cáncer

Juntos, realizarán pruebas a más de 30,000 participantes del estudio elegibles antes de 2023 para determinar el riesgo de cirrosis y enfermedades relacionadas con el hígado. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. La enfermedad de hígado graso no alcohólico (EHGNA), que incluye la EHNA, es frecuente en Nevada y está subdiagnosticada, y probablemente afecte a más de 500,000 adultos en nuestro estado. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. Hay más de 12,000 personas en la lista de espera para trasplante de hígado en los EE. UU. y esta cifra continúa aumentando debido al incremento en la prevalencia de la EHGNA. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. Es increíblemente gratificante poder informar hallazgos clínicos para ayudar a nuestros 50,000 participantes voluntarios del estudio y asistir a los proveedores de atención médica a ayudar a sus pacientes”. La provisión de la prueba de ELF se basa en una colaboración estratégica anunciada previamente entre el Renown IHI y Gilead en julio de 2019. Esta sociedad en curso tiene como objetivo recopilar y analizar datos de salud genéticos y electrónicos anónimos de 60,000 participantes del estudio elegibles con el fin de mejorar la comprensión de la EHGNA y la EHNA y para potencialmente orientar el desarrollo de opciones de tratamiento para estas enfermedades. Acerca de la EHGNA y la EHNA La EHGNA es una acumulación de grasa en el hígado en personas que no tienen antecedentes de abuso de alcohol. Es normal que el hígado contenga algo de grasa, pero si más del 5 por ciento del contenido hepático es grasa, se considera hígado graso (esteatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. Aproximadamente, un tercio de las personas con EHNA desarrollan cirrosis o daño hepático irreversible (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. Para obtener más información o para inscribirse, comuníquese a la casilla de correo RenownIHI@renown.org o al teléfono (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene más de 60,000 participantes. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. En el año fiscal 2020, que finalizó el 30 de septiembre de 2020, Siemens Healthineers, que tiene aproximadamente 54,000 empleados en todo el mundo, generó ingresos por €14.5 mil millones y un EBIT ajustado de €2.2 mil millones. Encontrará más información disponible en www.siemens-healthineers.com.Media Contacto de Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Leer más About Renown Institute Expands Partnership to Offer ELF Testing